MeSH D013736 - testicular neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Bleomycin | Bleomycin | 1996-06-01 | |||
| Etoposide | Etoposide | 1994-02-10 | ||||
| Ifosfamide, Mesna | Ifosfamide/mesna | 2002-02-26 | ||||
| Cyclophosphamide | Neosar | 1993-04-29 | ||||
| Oxaliplatin | Oxaliplatin | 2009-08-07 | ||||
| Etoposide | Toposar | 1995-02-27 | ||||
| Cisplatin | Cisplatin | 2000-05-16 | ||||
| Novast Laboratories | Oxaliplatin | Oxaliplatin | 2018-10-16 | |||
| Dr Reddys Laboratories | Cyclophosphamide | Cyclophosphamide | 2036-02-15 | 2020-07-30 | ||
| Mylan | Etoposide | Etoposide | 2001-09-19 | |||
| Oxaliplatin | Oxaliplatin | 2012-08-07 | ||||
| Cisplatin | Cisplatin | 2012-04-18 | ||||
| Methotrexate | Methotrexate | 1992-05-15 | ||||
| Rising Pharmaceuticals | Ifosfamide | Ifosfamide | 2012-11-26 | |||
| Methotrexate | Methotrexate | 2012-03-29 | ||||
| Cipla | Bleomycin | Bleomycin | 2019-03-11 | |||
| Cyclophosphamide | Cyclophosphamide | 2019-01-18 | ||||
| Sandoz | Oxaliplatin | Oxaliplatin | 2009-08-07 | |||
| Cyclophosphamide | Cyclophosphamide | 2023-09-12 | ||||
| Methotrexate | Methotrexate | 2009-03-31 | ||||
| Sanofi | Oxaliplatin | Eloxatin | 2002-08-09 | |||
| Eli Lilly | Vinblastine | Velban | 1982-01-01 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
75%6/8
Phase 2
19%5/27
Phase 3
82%14/17
Approved: 11Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use